Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder

被引：0
|
作者：
Greist, J. [1 ]
Liu-Dumaw, M. [2 ]
Feltner, D. [2 ]
机构：
[1] Univ Wisconsin, Madison Inst Med, Madison, WI 53706 USA
[2] Pfizer Inc, Global Res & Dev, New York, NY USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷
关键词：
D O I：
10.1016/S0924-977X(10)70785-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S525 / S525
页数：1
相关论文
共 50 条
  • [31] Pregabalin in generalized anxiety disorder: Influence of subsyndromic depression
    Pollack, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S377 - S377
  • [32] Generalized anxiety disorder with comorbidity.: Treatment with pregabalin
    Lauer, D.
    Hoelzel, L.
    Hornyak, M.
    [J]. NERVENARZT, 2006, 77 (11): : 1363 - +
  • [33] Pharmacotherapy Update: Pregabalin in the Treatment of Generalized Anxiety Disorder
    Montgomery, Stuart A.
    Kasper, Siegfried
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 189 - 202
  • [34] Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder
    Buoli, Massimiliano
    Caldiroli, Alice
    Serati, Marta
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (03) : 351 - 359
  • [35] Pregabalin's speed of onset of in generalized anxiety disorder
    Fieve, RR
    Sambunaris, A
    Trivedi, MH
    Kathy, T
    Brock, J
    Zornberg, GL
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S194 - S194
  • [36] EFFECT OF PREGABALIN ON GENERALIZED ANXIETY DISORDER PATIENTS WITH SEVERE SYMPTOMS OF ANXIETY AND DEPRESSION REFRACTORY TO DULOXETIN
    Olivares, J. M.
    Carrasco, J. L.
    Alvarez, E.
    Perez, M.
    Lopez-Gomez, V.
    Vilardaga, I.
    Rejas, J.
    [J]. EUROPEAN PSYCHIATRY, 2011, 26
  • [37] Pregabalin's speed of onset of in generalized anxiety disorder
    Fieve, RR
    Sambunaris, A
    Trivedi, MH
    Tobias, K
    Brock, JD
    Zornberg, GL
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 : 93S - 93S
  • [38] Population exposure response analysis of pregabalin in patients with generalized anxiety disorder (GAD).
    Lockwood, PA
    Kowalski, KG
    Corrigan, BW
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P90 - P90
  • [39] Efficacy of psychological treatments for generalized anxiety disorder and social phobia
    Ruhmland, M
    Margraf, J
    [J]. VERHALTENSTHERAPIE, 2001, 11 (01) : 27 - 40
  • [40] Efficacy of vortioxetine in working patients with generalized anxiety disorder
    Christensen, Michael Cronquist
    Loft, Henrik
    Florea, Ioana
    McIntyre, Roger S.
    [J]. CNS SPECTRUMS, 2019, 24 (02) : 249 - 257
12345